logo-loader
viewOkyo Pharma Limited

Market Report: Airline makers and travel firms fly after Boris reveals road map out of lockdown

FTSE 100 rose gently as investors digested Boris Johnson’s roadmap to recovery from Covid-19. London’s blue-chip index rose by 11 to 6,623, suggesting most of the well-leaked plan was already priced in.

British Airways owner IAG, aeroengine maker Rolls-Royce and aeroengineer Melrose were the best of the risers on renewed hopes for a return to normal soon.  Intercontinental Hotels was up for similar reasons even though it posted a US$280mln loss in 2020.

A sharp drop in the price of Bitcoin overnight has cost boss Elon Musk his status as the world’s richest man. Bitcoin has dropped 12% over the last 24 hours, a fall that might have been sparked by Musk himself, who tweeted over the weekend that prices of the cryptocurrency and fellow digital token Ethereum “do seem high lol”.

HSBC reinstated its dividend even though profits tumbled by more than a third in 2020. The bank also confirmed it would switch investment even more towards Asia in future and away from Europe and the US.

Among the small caps, OKYO Pharma Limited (LON:OKYO) has received a US patent for a potential new type of analgesic. It is being developed to treat symptoms of neuropathic pain and inflammation in the eyes and dry eye disease.  

World High Life PLC’s (LON:LIFE) (OTCQB:WRHLF) brand Love Hemp Limited has submitted its novel food dossier to the UK’s Food Standards Agency. The firm is looking to support the authorities in regulating the CBD market.  

Crossword Cybersecurity PLC (LON:CCS) has signed an agreement with the University of Glasgow to create new software to support a privacy risk and compliance project.

Quick facts: Okyo Pharma Limited

Price: 7.875 GBX

LSE:OKYO
Market: LSE
Market Cap: £52.98 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Okyo Pharma Limited named herein, including the promotion by the Company of Okyo Pharma Limited in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OKYO Pharma files patent application for Chemerin to treat COVID-19 and ARDS

OKYO Pharma (LON:OKYO) CEO Gary Jacob speaks to Proactive's Andrew Scott following the news it's submitted a patent application for the potential use of its molecule chemerin for the treatment of symptoms associated with COVID-19 and acute respiratory distress syndrome (ARDS). The project...

on 19/1/21

2 min read